Umezawa Y - Search Results

1

Kawamoto H, Hara H, Minagawa S, Numata T, Araya J, Kaneko Y, Umezawa Y, Asahina A, Nakagawa H, Kuwano K. Kawamoto H, et al. Among authors: umezawa y. Mayo Clin Proc Innov Qual Outcomes. 2018 Sep 20;2(4):370-377. doi: 10.1016/j.mayocpiqo.2018.07.006. eCollection 2018 Dec. Mayo Clin Proc Innov Qual Outcomes. 2018. PMID: 30560239 Free PMC article.

2

Effect of anti-interleukin-17 biologics on Krebs von den Lungen-6 level in patients with psoriasis.

Hara H, Miyagawa H, Araya J, Minagawa S, Numata T, Umezawa Y, Asahina A, Nakagawa H, Kuwano K. Hara H, et al. Among authors: umezawa y. J Dermatol. 2021 Jun;48(6):886-893. doi: 10.1111/1346-8138.15895. Epub 2021 Apr 16. J Dermatol. 2021. PMID: 33860559

3

Characteristics of anti-IL-17/23 biologics-induced interstitial pneumonia in patients with psoriasis.

Miyagawa H, Hara H, Araya J, Minagawa S, Numata T, Umezawa Y, Asahina A, Nakagawa H, Kuwano K. Miyagawa H, et al. Among authors: umezawa y. PLoS One. 2021 Jan 7;16(1):e0245284. doi: 10.1371/journal.pone.0245284. eCollection 2021. PLoS One. 2021. PMID: 33411857 Free PMC article.

4

Some clinical factors affecting quality of the response to ustekinumab for psoriasis.

Umezawa Y, Saeki H, Nakagawa H. Umezawa Y, et al. J Dermatol. 2014 Aug;41(8):690-6. doi: 10.1111/1346-8138.12538. Epub 2014 Jul 9. J Dermatol. 2014. PMID: 25040159

5

Ustekinumab treatment in patients with psoriasis undergoing hemodialysis.

Umezawa Y, Hayashi M, Kikuchi S, Fukuchi O, Yanaba K, Ito T, Asahina A, Saeki H, Nakagawa H. Umezawa Y, et al. J Dermatol. 2015 Jul;42(7):731-4. doi: 10.1111/1346-8138.12903. Epub 2015 May 11. J Dermatol. 2015. PMID: 25959602

6

Interstitial pneumonia in two patients with psoriasis during ustekinumab treatment.

Kikuchi S, Umezawa Y, Hayashi M, Yanaba K, Fukuchi O, Ito T, Asahina A, Saeki H, Nakagawa H. Kikuchi S, et al. Among authors: umezawa y. J Dermatol. 2016 Jun;43(6):712-3. doi: 10.1111/1346-8138.13250. Epub 2015 Dec 24. J Dermatol. 2016. PMID: 26703791 No abstract available.

7

Serum C-reactive protein levels in Japanese patients with psoriasis and psoriatic arthritis: Long-term differential effects of biologics.

Asahina A, Umezawa Y, Yanaba K, Nakagawa H. Asahina A, et al. Among authors: umezawa y. J Dermatol. 2016 Jul;43(7):779-84. doi: 10.1111/1346-8138.13213. Epub 2015 Dec 24. J Dermatol. 2016. PMID: 26704718

8

Relapsing polychondritis associated with psoriasis vulgaris successfully treated with adalimumab: A case report with published work review.

Matsuo H, Asahina A, Fukuda T, Umezawa Y, Nakagawa H. Matsuo H, et al. Among authors: umezawa y. J Dermatol. 2017 Jul;44(7):826-829. doi: 10.1111/1346-8138.13796. Epub 2017 Mar 7. J Dermatol. 2017. PMID: 28266051 Review.

9

Impact of anti-tumor necrosis factor-α agents on serum levels of KL-6 and surfactant protein-D in patients with psoriasis.

Hayashi M, Yanaba K, Umezawa Y, Asahina A, Nakagawa H. Hayashi M, et al. Among authors: umezawa y. J Dermatol. 2017 Sep;44(9):1063-1066. doi: 10.1111/1346-8138.13837. Epub 2017 Mar 31. J Dermatol. 2017. PMID: 28370220

10

Biologic treatments for elderly patients with psoriasis.

Momose M, Asahina A, Hayashi M, Yanaba K, Umezawa Y, Nakagawa H. Momose M, et al. Among authors: umezawa y. J Dermatol. 2017 Sep;44(9):1020-1023. doi: 10.1111/1346-8138.13853. Epub 2017 Apr 25. J Dermatol. 2017. PMID: 28439956

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

390 results

Search Page

Filters